Evidence map›Paper›PMID 18279813›Full record

ArticleTranslational research : the journal of laboratory and clinical medicine2008

A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age.

Jaideep Moitra, Carrie Evenoski, Saad Sammani, Raj Wadgaonkar, Jerrold R Turner, Shwu Fan Ma, Joe G N Garcia

Open access · greenAbstract read
In one paragraph

Article in Translational research : the journal of laboratory and clinical medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene.American journal of respiratory cell and molecular biology · 2018
    Article
  7. Splice Wars: The Role of MLCK Isoforms in Ventilation-induced Lung Injury.American journal of respiratory cell and molecular biology · 2018
    Article
  8. Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  9. Mechanical Stress and Single Nucleotide Variants Regulate Alternative Splicing of the MYLK Gene.American journal of respiratory cell and molecular biology · 2017
    Article
  10. Article
  11. Article
  12. Nonmuscle myosin light chain kinase regulates murine asthmatic inflammation.American journal of respiratory cell and molecular biology · 2014
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Biochemistry of smooth muscle myosin light chain kinase.Archives of biochemistry and biophysics · 2011
    Review
  19. Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression.American journal of respiratory cell and molecular biology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jaideep MoitraDepartment of Medicine, University of Chicago, Chicago, Il 60637-1470, USA.
Carrie Evenoski
Saad Sammani
Raj Wadgaonkar
Jerrold R Turner
Shwu Fan Ma
Joe G N Garcia
University of Chicago · US

Funding

VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHESP50HL073994 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BROWER, ROY G. · 2003 to 2007
$21.3M
ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
NHLBI NIH HHS P50 HL073994NHLBI NIH HHS P50 HL 73994NHLBI NIH HHS PPG HL 50864NIDDK NIH HHS DK61931NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271
6 · The paper itself

Abstract

We have generated genetically engineered mice that are uniquely susceptible to lipopolysaccharide (LPS)-induced and mechanical ventilation-induced lung injury in a sex-specific and age-specific manner. These mice express a nonmuscle isoform of the myosin light chain kinase gene (nmMLCK2) targeted to the endothelium. Homozygous mice have significantly reduced fecundity and litter survival until weaning, and they are initially growth delayed but eventually exceed the size of wild-type littermates. Mice at all ages show increased protein transport across the lung barrier; however, the phenotype is most discernible in 8-12-week-old male mice. When subjected to a clinically relevant LPS-induced lung injury model, 8-12-week-old young females and 30-36-week-old males seem to be the most significantly injured group. In contrast, 30-36-week-old males remain the most significantly injured group when mechanically ventilated at high tidal volumes, which is a clinically relevant model of mechanical stress lung injury. These data reveal that nmMLCK2 overexpression in the endothelium exacerbates lung injury in vivo in a sexually dimorphic and age-dependent manner.

Indexed as

Disease Models, AnimalAge FactorsAnimalsBronchoalveolar Lavage FluidDisease SusceptibilityEndothelium, VascularFemaleGene ExpressionHomozygoteHumansIsoenzymesLipopolysaccharidesMaleMiceMice, TransgenicMyosin-Light-Chain KinaseIsoenzymesLipopolysaccharidesMyosin-Light-Chain Kinase

Identifiers

PMID18279813
PMCPMC2693047
OpenAlexW2153350387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.